One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Feasibility of prevention of type 2 diabetes in low- and middle-income countries
Andre P. Kengne & Ambady Ramachandran
Keeping pace: the primary cilium as the conducting baton of the islet
Olof Idevall-Hagren, Ceren Incedal Nilsson & Gonzalo Sanchez
Harnessing the power of proteomics in precision diabetes medicine
Nigel Kurgan, Jeppe Kjærgaard Larsen & Atul S. Deshmukh
Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis
Milena Jancev, Tessa A. C. M. Vissers, Frank L. J. Visseren, Arianne C. van Bon, Erik H. Serné, J. Hans DeVries, Harold W. de Valk & Thomas T. van Sloten
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial
Heikki Hyöty, Susanna Kääriäinen, Jutta E. Laiho, Gail M. Comer, Wei Tian, Taina Härkönen, Jussi P. Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Mikael Knip & Miguel Sanjuan
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
Pedro Cardoso, Katie G. Young, Anand T. N. Nair, Rhian Hopkins, Andrew P. McGovern, Eram Haider, Piyumanga Karunaratne, Louise Donnelly, Bilal A. Mateen, Naveed Sattar, Rury R. Holman, Jack Bowden, Andrew T. Hattersley, Ewan R. Pearson, Angus G. Jones, Beverley M. Shields, Trevelyan J. McKinley & John M. Dennis on behalf of the MASTERMIND consortium
Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank
Qiao Jin, Eric S. H. Lau, Andrea O. Luk, Claudia H. T. Tam, Risa Ozaki, Cadmon K. P. Lim, Hongjiang Wu, Elaine Y. K. Chow, Alice P. S. Kong, Heung Man Lee, Baoqi Fan, Alex C. W. Ng, Guozhi Jiang, Ka Fai Lee, Shing Chung Siu, Grace Hui, Chiu Chi Tsang, Kam Piu Lau, Jenny Y. Leung, Man-wo Tsang, Elaine Y. N. Cheung, Grace Kam, Ip Tim Lau, June K. Li, on behalf of the Hong Kong Diabetes Biobank Study GroupShow authors
Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment
Mengqi Su, Yilin Hou, Sidong Cai, Wenpeng Li, Yinxia Wei, Run Wang, Min Wu, Mingya Liu, Junlei Chang, Kelaier Yang, Kaihang Yiu & Cong Chen
Child-to-adult body size change and risk of type 2 diabetes and cardiovascular disease
Germán D. Carrasquilla, Lars Ängquist, Thorkild I. A. Sørensen, Tuomas O. Kilpeläinen & Ruth J. F. Loos
Low birthweight and overweight during childhood and young adulthood and the risk of type 2 diabetes in men: a population-based cohort study
Jimmy Célind, Maria Bygdell, Rebecka Bramsved, Jari Martikainen, Claes Ohlsson & Jenny M. Kindblom
An omics-based machine learning approach to predict diabetes progression: a RHAPSODY study
Roderick C. Slieker, Magnus Münch, Louise A. Donnelly, Gerard A. Bouland, Iulian Dragan, Dmitry Kuznetsov, Petra J. M. Elders, Guy A. Rutter, Mark Ibberson, Ewan R. Pearson, Leen M. ’t Hart, Mark A. van de Wiel & Joline W. J. Beulens
Metabolomic and genetic architecture of gestational diabetes subtypes
Kristen Lee, Alan Kuang, James R. Bain, M. Geoffrey Hayes, Michael J. Muehlbauer, Olga R. Ilkayeva, Christopher B. Newgard, Camille E. Powe, Marie-France Hivert, Denise M. Scholtens & William L. Lowe Jr
Interferons are key cytokines acting on pancreatic islets in type 1 diabetes
Alexandra Coomans de Brachène, Maria Ines Alvelos, Florian Szymczak, Priscila L. Zimath, Angela Castela, Bianca Marmontel de Souza, Arturo Roca Rivada, Sandra MarÃn-Cañas, Xiaoyan Yi, Anne Op de Beeck, Noel G. Morgan, Sebastian Sonntag, Sayro Jawurek, Alexandra C. Title, Burcak Yesildag, François Pattou, Julie Kerr-Conte, Eduard Montanya, Montserrat Nacher, Lorella Marselli, Piero Marchetti, Sarah J. Richardson & Decio L. Eizirik
Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: the LIFE-Adult-Study
Franziska G. Rauscher, Tobias Elze, Mike Francke, M. Elena Martinez-Perez, Yangjiani Li, Kerstin Wirkner, Anke Tönjes, Christoph Engel, Joachim Thiery, Matthias Blüher, Michael Stumvoll, Toralf Kirsten, Markus Loeffler, Thomas Ebert & Mengyu Wang
A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life
Natascia Vedovato, Maria V. Salguero, Siri Atma W. Greeley, Christine H. Yu, Louis H. Philipson & Frances M. Ashcroft
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?
Rosa M. Sánchez-Hernández & Ana M. Wägner
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention
Frans Pouwer & Sonya Deschênes
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]
Merel M. Ruissen, Ewout W. Steyerberg, Sasja D. Huisman, Albert A. de Graaf, Eelco J. P. de Koning, Javier Delgado-Lista & Jacob K. Sont
Correction to: Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research
Jeremy Basset‑Sagarminaga, Tineke van de Weijer, Patricia Iozzo, Patrick Schrauwen & Vera Schrauwen‑Hinderling
